Research Article

FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway

Figure 3

Survival analysis of patients with high and low FKBP4 expression groups; log-rank test, , .